Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
Part of paid clinical trials in Loma Linda, California.
- Sponsor
- Loma Linda University
- Study ID
- NCT06553131
- Status
- Recruiting
Conditions
- Neuromuscular Blockade
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Neuromuscular Transmission Monitoring — DEVICEA neuromuscular transmission module connected to electrodes applied to the skin and positioned to provide stimulation of a single nerve and monitor the muscular response to nerve stimulation
Study Details
Medications used to relax the muscles are used during surgery. The amount of muscle relaxation can monitored with devices that stimulate a specific nerve and evaluate the muscle response. The response to, and recovery from, medications that relax the muscles are best described for a nerve in the arm called the ulnar nerve. The investigators believe that other nerves in the arm, such as the median nerve, could be used to monitor the amount of muscle relaxation. The purpose of this study is to compare the muscle response at two different nerve sites after giving medications to relax the muscles. This study is going to measure the depth of muscle relaxation during surgery at two different sites. The muscle response to stimulation of the ulnar nerve (located in the arm) will be compared to the muscle response to stimulation of the median nerve (also located in the arm).
Key Dates
- Start date
- Dec 26, 2024
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 32 participants (estimated)
Arms
- Arm: Surgical Patients Receiving Non-Depolarizing Neuromuscular BlockadeSurgical patients having surgery that requires muscle relaxation with non-depolarizing neuromuscular blockers and monitoring of the depth of muscle blockade.The muscle response to nerve stimulation will be compared between the ulnar and median nerve.
Primary Outcome Measure
Neuromuscular transmission nerve monitoring concordance [ Time Frame: Change in time between administration of rocuronium at beginning of surgery and the appearance of one post-tetanic twitch on a monitor, typically 20 minutes after sedation ]
Central Contacts
- Melissa D McCabe, MD, MSCR909 558 4475
- Michael Benggon, MD909 558 4475
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loma Linda University Troesch Medical Center | Loma Linda | California | 92354 | Melissa D McCabe, MD (PRINCIPAL_INVESTIGATOR) Edgardo E Reynoso, BA (SUB_INVESTIGATOR) Richard L Applegate, MD (SUB_INVESTIGATOR) Lauren S Pineda, MS (SUB_INVESTIGATOR) Morgan E Blazy, BS (SUB_INVESTIGATOR) Michael Benggon, MD (SUB_INVESTIGATOR) Ryan Lauer, MD (SUB_INVESTIGATOR) |
Find similar trials in Loma Linda, CA
Related Studies
- Comparison of Sugammadex and Neostigmine During PACU StayPHASE3 · Not Yet Recruiting · University of South Florida · Tampa, Florida
- Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney DiseasePHASE4 · Recruiting · The University of Texas Medical Branch, Galveston · Galveston, Texas